Zobrazeno 1 - 10
of 16
pro vyhledávání: '"тенектеплаза"'
В данной статье рассматривается актуальная статистика по оказанию скорой медицинской неотложной помощи при остром коронарном синдром
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fcb60a8c2b5914720718de2a758b6df
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 7, Iss 2, Pp 145-150 (2016)
Aim. To evaluate clinical and cost effectiveness of different reperfusion strategies in myocardial infarction with ST segment elevation (STEMI), including pre-hospital thrombolysis with tenecteplase. Material and methods. Methods of cost-effectivenes
Externí odkaz:
https://doaj.org/article/6e5a3e3db45a4c0c9a07c5de6d0a8602
Autor:
L. A. Ostroumova, S. V. Shalaev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 4, Pp 521-525 (2015)
Aim. To identify the factors of the increasing the availability and effectiveness of pre-hospital thrombolytic therapy of patients with ST segment elevation acute coronary syndrome (STEACS). Material and methods. STEACS patients (n=70) were included
Externí odkaz:
https://doaj.org/article/9e0f7ac69db74af0aec8dc7fe5970b47
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 5, Pp 685-690 (2015)
Aim. To evaluate the clinical results of thrombolytic therapy with thrombolytics (alteplase, tenecteplase) in patients with ST segment elevation myocardial infarction (STEMI). Material and methods. Patients with STEMI (n=181) included in the study we
Externí odkaz:
https://doaj.org/article/eea48c982a0949f99024fd869bfcf452
Цель. Оценка влияния комплексного применения фозиноприла, пропранолола с гепарином и чрескожного коронарного вмешательства (ЧКВ); тене
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::667ef34c6659e4b498a3a902814ce348
Publikováno v:
Актуальні питання фармацевтичної та медичної науки та практики; № 2 (2018)
Current issues in pharmacy and medicine: science and practice; № 2 (2018)
Актуальные вопросы фармацевтической и медицинской науки и практики; № 2 (2018)
Current issues in pharmacy and medicine: science and practice; № 2 (2018)
Актуальные вопросы фармацевтической и медицинской науки и практики; № 2 (2018)
Оne of the modern evidence-based methods for treating patients with ischemic stroke is systemic thrombolytic therapy. Only alteplase is allowed for systemic thrombolytic therapy. But this medical drug have restriction to use and a number of serious
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 7, Iss 2, Pp 145-150 (2016)
Aim. To evaluate clinical and cost effectiveness of different reperfusion strategies in myocardial infarction with ST segment elevation (STEMI), including pre-hospital thrombolysis with tenecteplase. Material and methods. Methods of cost-effectivenes
Autor:
S. V. Shalaev, L. A. Ostroumova
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 8, Iss 4, Pp 521-525 (2015)
Aim. To identify the factors of the increasing the availability and effectiveness of pre-hospital thrombolytic therapy of patients with ST segment elevation acute coronary syndrome (STEACS). Material and methods. STEACS patients (n=70) were included
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 8, Iss 5, Pp 685-690 (2015)
Aim. To evaluate the clinical results of thrombolytic therapy with thrombolytics (alteplase, tenecteplase) in patients with ST segment elevation myocardial infarction (STEMI). Material and methods. Patients with STEMI (n=181) included in the study we
Publikováno v:
Медицина неотложных состояний.
В статье обсуждаются вопросы организации медицинской помощи, и в частности, возможности и проблемы применения реперфузионной терапии п